Related references
Note: Only part of the references are listed.Changes in circulating microRNA levels associated with prostate cancer
R. J. Bryant et al.
BRITISH JOURNAL OF CANCER (2012)
miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
Jong-Kook Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
Jipeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
Felix Moltzahn et al.
CANCER RESEARCH (2011)
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage
Yasuhide Kuwabara et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Sota Asaga et al.
CLINICAL CHEMISTRY (2011)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer
Jason C. Gonzales et al.
CLINICAL GENITOURINARY CANCER (2011)
Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis
Xiangyu Kong et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
miRNAs as serum biomarkers for Duchenne muscular dystrophy
Davide Cacchiarelli et al.
EMBO MOLECULAR MEDICINE (2011)
Circulating MicroRNAs as Potential Markers of Human Drug-Induced Liver Injury
Philip J. Starkey Lewis et al.
HEPATOLOGY (2011)
Circulating miRNAs are correlated with tumor progression in prostate cancer
Jan C. Brase et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Downregulation of Sec23A Protein by miRNA-375 in Prostate Carcinoma
Jaroslaw Szczyrba et al.
MOLECULAR CANCER RESEARCH (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
MicroRNAs in body fluids-the mix of hormones and biomarkers
Maria Angelica Cortez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
Hanyin Cheng et al.
PLOS ONE (2011)
Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy
Hideya Mizuno et al.
PLOS ONE (2011)
Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
Radha Duttagupta et al.
PLOS ONE (2011)
Tissue and Serum microRNAs in the KrasG12D Transgenic Animal Model and in Patients with Pancreatic Cancer
Joseph J. LaConti et al.
PLOS ONE (2011)
Haemolysis during Sample Preparation Alters microRNA Content of Plasma
Michaela B. Kirschner et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Parsimonious Model for Gene Regulation by miRNAs
Sergej Djuranovic et al.
SCIENCE (2011)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Fulya Yaman Agaoglu et al.
TUMOR BIOLOGY (2011)
Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer
Robert Mahn et al.
UROLOGY (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
The role of let-7 in cell differentiation and cancer
Benjamin Boyerinas et al.
ENDOCRINE-RELATED CANCER (2010)
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Zhaohui Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Nobuyoshi Kosaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
Xing-xiang Pu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin
Shai Rosenwald et al.
MODERN PATHOLOGY (2010)
Serum microRNAs as non-invasive biomarkers for cancer
Jan C. Brase et al.
MOLECULAR CANCER (2010)
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
Jaroslaw Szczyrba et al.
MOLECULAR CANCER RESEARCH (2010)
Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration
Yujing Zhang et al.
MOLECULAR CELL (2010)
MicroRNA Binding-Site Polymorphisms as Potential Biomarkers of Cancer Risk
Rachel C. Blitzblau et al.
MOLECULAR DIAGNOSIS & THERAPY (2010)
Cell signalling by microRNA165/6 directs gene dose-dependent root cell fate
Annelie Carlsbecker et al.
NATURE (2010)
Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors
Annika Schaefer et al.
NATURE REVIEWS UROLOGY (2010)
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
Evan M. Kroh et al.
METHODS (2010)
Export of microRNAs and microRNA-protective protein by mammalian cells
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
Ramesh Narayanan et al.
PLOS ONE (2010)
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Lucy Pigati et al.
PLOS ONE (2010)
Functional delivery of viral miRNAs via exosomes
D. Michiel Pegtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Complexity of the microRNA repertoire revealed by next-generation sequencing
Lik Wee Lee et al.
RNA (2010)
Genetic variation in microRNA networks: the implications for cancer research
Brid M. Ryan et al.
NATURE REVIEWS CANCER (2010)
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Carina Roth et al.
BREAST CANCER RESEARCH (2010)
Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs
Erin K. Hanson et al.
ANALYTICAL BIOCHEMISTRY (2009)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
Tong Sun et al.
CANCER RESEARCH (2009)
Let-7 and miR-200 microRNAs Guardians against pluripotency and cancer progression
Marcus E. Peter
CELL CYCLE (2009)
The role of microRNAs in metastasis and epithelial-mesenchymal transition
C. P. Bracken et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection
Noh Jin Park et al.
CLINICAL CANCER RESEARCH (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Many roads to maturity: microRNA biogenesis pathways and their regulation
Julia Winter et al.
NATURE CELL BIOLOGY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles
Alex Yuan et al.
PLOS ONE (2009)
Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray
Michael J. Lodes et al.
PLOS ONE (2009)
Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
Alma Zernecke et al.
SCIENCE SIGNALING (2009)
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
Robert L. Grubb et al.
BJU INTERNATIONAL (2008)
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
M. Scott Lucia et al.
CANCER PREVENTION RESEARCH (2008)
A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non-Small Cell Lung Cancer Risk
Lena J. Chin et al.
CANCER RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues
Anna E. y Szafranska et al.
CLINICAL CHEMISTRY (2008)
Detection and characterization of placental MicroRNAs in maternal plasma
Stephen S. C. Chim et al.
CLINICAL CHEMISTRY (2008)
Serum markers for prostate cancer: A rational approach to the literature
Thomas Steuber et al.
EUROPEAN UROLOGY (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
The emergent role of microRNAs in molecular diagnostics of cancer
Wayne Tam
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Michel P. Coleman et al.
LANCET ONCOLOGY (2008)
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld et al.
NATURE BIOTECHNOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples
Yaguang Xi et al.
RNA (2007)
A mammalian microRNA expression atlas based on small RNA library sequencing
Pablo Landgraf et al.
CELL (2007)
Discovery of cancer biomarkers through the use of mouse models
Rork Kuick et al.
CANCER LETTERS (2007)
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Jon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
HI Scher et al.
ENDOCRINE-RELATED CANCER (2004)
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: Results from cancer of the prostate strategic urological research endeavor (CaPSURE)
KL Greene et al.
JOURNAL OF UROLOGY (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dicer is essential for mouse development
E Bernstein et al.
NATURE GENETICS (2003)
DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
D Hessels et al.
EUROPEAN UROLOGY (2003)
The microRNA-producing enzyme Dicer1 is essential for zebrafish development
E Wienholds et al.
NATURE GENETICS (2003)
Share Paper
